Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Recurrent or Progressive CNS Tumors
NCT00025675Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2001
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in malignant glioma, meningioma, hemangiopericytoma (HPC), glioblastoma (GBM), astrocytoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2001; status: completed.
02
Drugs
03
Conditions
malignant gliomameningiomahemangiopericytoma (HPC)glioblastoma (GBM)astrocytoma
Beyond the preview
Go deeper on NCT00025675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025675.